The role of technology in driving developments in healthcare, life sciences and pharmaceuticals
The healthcare, life sciences and pharmaceutical industries are typically the slowest to adopt new technologies given the highly regulated and risk-averse nature of their operations.
However, partly triggered by the COVID-19 pandemic, artificial intelligence (AI), 5G and cloud technology are driving developments at a never-before-seen rate. Research is ongoing to understand how we can fully capitalise on their benefits whilst utilising them ethically and safely at scale. Our report delves into the opportunities these new technologies present across the health industries, and the challenges that must be overcome.
- Delving into AI, 5G and cloud platforms- what are the opportunities and challenges?
- How technology supports these industries
- Looking towards an innovative future